Literature DB >> 14972088

Genes for left ventricular hypertrophy.

Donna K Arnett1, Lisa de las Fuentes, Ulrich Broeckel.   

Abstract

Left ventricular (LV) hypertrophy is very common, particularly among hypertensives. The presence of LV hypertrophy profoundly affects morbidity and mortality from cardiovascular diseases and stroke, and is now recognized as the most important predictor of chronic heart failure. Hypertension, obesity, and diabetes are important determinants of LV hypertrophy, but they fail to identify many individuals with the condition, suggesting that other factors, likely genetic in origin, play a role. Although much research has been undertaken to understand the causes of hypertrophy and the medical treatments that can lead to its regression, much remains unknown about its genetic basis. LV hypertrophy is considered a complex genetic disease, likely representing an interaction of several genes with the environment. The heritability of LV mass, measured as a quantitative trait, falls between 0.3 and 0.7 in different populations, suggesting it has a familial component. Genes encoding proteins involved in LV structure, as well as genes encoding cell signal transduction, hormones, growth factors, calcium homeostasis, substrate metabolism, and blood pressure are likely candidates for the development of common forms of LV hypertrophy. An overview of the pathophysiology of LV hypertrophy and dysfunction is provided, in addition to evidence of the genetic basis for LV hypertrophy in humans and animal models.

Entities:  

Mesh:

Year:  2004        PMID: 14972088     DOI: 10.1007/s11906-004-0009-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  60 in total

1.  Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction.

Authors:  Marcel Peltier; Michel Slama; Sami Garbi; Maurice L Enriquez-Sarano; Thomas Goissen; Christophe M Tribouilloy
Journal:  Am J Cardiol       Date:  2002-12-01       Impact factor: 2.778

Review 2.  Altered interactions among thin filament proteins modulate cardiac function.

Authors:  R J Solaro; J Van Eyk
Journal:  J Mol Cell Cardiol       Date:  1996-02       Impact factor: 5.000

3.  New target regions for human hypertension via comparative genomics.

Authors:  M Stoll; A E Kwitek-Black; A W Cowley; E L Harris; S B Harrap; J E Krieger; M P Printz; A P Provoost; J Sassard; H J Jacob
Journal:  Genome Res       Date:  2000-04       Impact factor: 9.043

4.  Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value.

Authors:  Mei Wang; Gabriel W K Yip; Angela Y M Wang; Yan Zhang; Pik Yuk Ho; Mui Kiu Tse; Peggo K W Lam; John E Sanderson
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

5.  Automated construction of high-density comparative maps between rat, human, and mouse.

Authors:  A E Kwitek; P J Tonellato; D Chen; J Gullings-Handley; Y S Cheng; S Twigger; T E Scheetz; T L Casavant; M Stoll; M A Nobrega; M Shiozawa; M B Soares; V C Sheffield; H J Jacob
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

6.  Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension.

Authors:  G de Simone; M J Roman; M J Koren; G A Mensah; A Ganau; R B Devereux
Journal:  Hypertension       Date:  1999-03       Impact factor: 10.190

7.  The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy.

Authors:  Stephen B Harrap; Vennetia R Danes; Justine A Ellis; Cory D Griffiths; Elizabeth F Jones; Leanne M D Delbridge
Journal:  Physiol Genomics       Date:  2002       Impact factor: 3.107

8.  Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with hypertension in middle-aged men.

Authors:  Hannes Oberkofler; Bertram Hölzl; Harald Esterbauer; Mingqiang Xie; Bernhard Iglseder; Franz Krempler; Bernhard Paulweber; Wolfgang Patsch
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

9.  Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.

Authors:  J K Ghali; Y Liao; R S Cooper
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

Review 10.  Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Authors:  G Bonne; L Carrier; P Richard; B Hainque; K Schwartz
Journal:  Circ Res       Date:  1998-09-21       Impact factor: 17.367

View more
  15 in total

1.  Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis.

Authors:  Xiaobo Li; Yuqiong Li; Nan Jia; Shujie Guo; Shaoli Chu; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2012-07-07       Impact factor: 2.316

2.  Usefulness of desirable lifestyle factors to attenuate the risk of heart failure among offspring whose parents had myocardial infarction before age 55 years.

Authors:  Owais Khawaja; Gregory Kotler; John Michael Gaziano; Luc Djoussé
Journal:  Am J Cardiol       Date:  2012-04-18       Impact factor: 2.778

Review 3.  Increased left ventricular mass as a predictor of sudden cardiac death: is it time to put it to the test?

Authors:  Steven M Stevens; Kyndaron Reinier; Sumeet S Chugh
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02

Review 4.  Myocardial remodeling in hypertension.

Authors:  W Nadruz
Journal:  J Hum Hypertens       Date:  2014-05-08       Impact factor: 3.012

5.  Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.

Authors:  Ramachandran S Vasan; Nicole L Glazer; Janine F Felix; Wolfgang Lieb; Philipp S Wild; Stephan B Felix; Norbert Watzinger; Martin G Larson; Nicholas L Smith; Abbas Dehghan; Anika Grosshennig; Arne Schillert; Alexander Teumer; Reinhold Schmidt; Sekar Kathiresan; Thomas Lumley; Yurii S Aulchenko; Inke R König; Tanja Zeller; Georg Homuth; Maksim Struchalin; Jayashri Aragam; Joshua C Bis; Fernando Rivadeneira; Jeanette Erdmann; Renate B Schnabel; Marcus Dörr; Robert Zweiker; Lars Lind; Richard J Rodeheffer; Karin Halina Greiser; Daniel Levy; Talin Haritunians; Jaap W Deckers; Jan Stritzke; Karl J Lackner; Uwe Völker; Erik Ingelsson; Iftikhar Kullo; Johannes Haerting; Christopher J O'Donnell; Susan R Heckbert; Bruno H Stricker; Andreas Ziegler; Thorsten Reffelmann; Margaret M Redfield; Karl Werdan; Gary F Mitchell; Kenneth Rice; Donna K Arnett; Albert Hofman; John S Gottdiener; Andre G Uitterlinden; Thomas Meitinger; Maria Blettner; Nele Friedrich; Thomas J Wang; Bruce M Psaty; Cornelia M van Duijn; H-Erich Wichmann; Thomas F Munzel; Heyo K Kroemer; Emelia J Benjamin; Jerome I Rotter; Jacqueline C Witteman; Heribert Schunkert; Helena Schmidt; Henry Völzke; Stefan Blankenberg
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

6.  Genetic epidemiology of left ventricular hypertrophy.

Authors:  Jonathan N Bella; Harald Hh Göring
Journal:  Am J Cardiovasc Dis       Date:  2012-10-25

7.  Parental history of myocardial infarction and risk of heart failure in male physicians.

Authors:  L Djoussé; J M Gaziano
Journal:  Eur J Clin Invest       Date:  2008-12       Impact factor: 4.686

8.  Association between transforming growth factor beta1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects.

Authors:  Hai-Ying Xu; Xu-Wei Hou; Li-Fang Wang; Ning-Fu Wang; Jian Xu
Journal:  Mol Cell Biochem       Date:  2009-08-29       Impact factor: 3.396

9.  Left ventricular cardiac geometry and ambulatory blood pressure in children.

Authors:  Steffi Shilly; Kumail Merchant; Pamela Singer; Rachel Frank; Shari Gurusinghe; Lulette Infante; Christine B Sethna
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-13       Impact factor: 3.738

10.  A follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genes.

Authors:  David Della-Morte; Ashley Beecham; Tatjana Rundek; Liyong Wang; Mark S McClendon; Susan Slifer; Susan H Blanton; Marco R Di Tullio; Ralph L Sacco
Journal:  BMC Med Genet       Date:  2011-07-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.